Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease (LOPD)
![](/.imaging/webp/sanofi-templates/article-hero-w768/dam/campus-sanofi-sa/new/science/hero/jcr_content-(34).jpg/jcr:content/jcr_content%20(34).jpg)
Objective and Method
![](/dam/jcr:c2f23100-5ce2-47cf-80b0-fa17fee410c4/Asset%204@4x-100%20(1).jpg)
Consensus based on literature supporting clinical presentation and recommendations
![](/dam/jcr:7db3901d-148c-49be-81f7-0d26953812d3/Asset%205@4x%20(1).jpg)
Neurology-Specific Clinical Presentation for Pediatric/Juvenile*and Adult# LOPD Proposed During the First Meeting
Pediatric/Juvenile* LOPD
- Delayed motor milestones
- Low/absent reflexes
- Mild facial muscle weakness
- HyperCKemia/paucisymptomatic
- Negative SMA/DMD
- Shortness of breath at rest or on effort
- Muscle pain and elevated ALT/AST
- Gait abnormalities
- Scoliosis/scapular winging
- Disproportional weakness of the neck flexors and difficulty in raising the head
Adult# LOPD
- LGMW
- Swallowing difficulties
- Frequent falls
- Difficulty chewing/jaw muscle fatigue
- Difficulty in walking and climbing stairs
- Double-seronegative MG
- Muscle pain and elevated ALT/AST
- Gait abnormalities
- HyperCKemia/paucisymptomatic
- Unexplained myopathy
- Scoliosis/scapular winging
High CK/elevated LDH,
ALT,and AST
Family history of unexplained
muscle weakness or respiratory
failure
Proposed Diagnostic Algorithm for Neurologists During the Second Meeting
Conclusion
![](/dam/jcr:f7fe8f3a-8216-436d-b7ae-5fec0095e388/Asset%2029@4x%20(1).jpg)
![](/dam/jcr:01e59ee6-8d81-467b-accb-461e615fb47c/Asset%2033@4x%20(1).jpg)
Recommendation
Testing for Pompe disease must be done if any one specialty-specific symptom plus elevated CK/LDH/ALT/AST or a family history of unexplained muscle weakness is present.
*The age of patients with pediatric/juvenile LOPD ranges from 1 to 17 years; #The age of patients with adult LOPD is usually 18 years and above.
Abbreviations
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CK: Creatine kinase; DBS: Dried blood spot testing; DMD: Duchenne muscular dystrophy; KSA: Kingdom of Saudi Arabia; LDH: Lactate dehydrogenase; LGMW: Limb–girdle muscle weakness; LOPD: Late-onset Pompe disease; MG: Myasthenia gravis; SMA: Spinal muscular atrophy; UAE: United Arab Emirates.
Reference
- Al Shehri A, Al-Asmi A, Al Salti AM, et al. A multidisciplinary perspective addressing the diagnostic challenges of late-onset Pompe disease in the Arabian Peninsula region developed from an Expert Group Meeting. J Neuromuscul Dis. 2022;9(5):661–673.